Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To analyze the effects of hyaluronidase and hirudoid treatment on drug extravasation in neonates.
Methods: The medical records of 13 neonates with drug extravasation treated with hyaluronidase and hirudoid between August 1(st), 2010 and May 1(st), 2012 were analyzed retrospectively. The treatment procedure for drug extravasation adhered to the protocol in neonatal department. The information including age, sex, weight, diagnosis, size of affected area, site of extravasation and treatment was collected. Findings : The extravasation injuries alleviated and the symptoms improved after treatment, no adverse drug effects were reported with use of hyaluronidase and hirudoid.
Conclusion: The treatment appeared to be beneficial in the management of extravasations of various medications in neonates and may be useful in reducing the severity of cutaneous toxicosis. However, further studies with large samples are still needed to assess the effectiveness and safety of hyaluronidase and hirudoid.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339556 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Nursing Care in the Management of Injuries Due to Vasoactive Drug Extravasation: Scoping Review.
J Infus Nurs
September 2025
Author Affiliations: Department of Nursing, Federal University of Rio Grande do Norte, Natal, Brazil (Lima, Sena, Bispo, Chagas, Ribeiro, and de Oliveira Araújo).
Objective: The aim of this study was to map nursing care in the treatment of lesions due to vasoactive drug extravasation. This scoping review is built according to the recommendations of the Joanna Briggs Institute and PRISMA-ScR.
Methods: The review was carried out from July to August 2022, across 12 data sources.
Albumin Nanocages with Methotrexate and Chondroitin Sulfate as a Dual pH/GSH-Responsive Tumor Targeting Nanomedicine for Synergistic Cancer Therapy.
Biomater Res
September 2025
Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
Cancer is a devastating disease, and its pathogenesis is highly associated with malnutrition and poor lifestyle. Chemotherapy continuously causes inadequate therapeutic efficacy and induces off-target toxicities. Hence, targeted co-administration of chemotherapy and dietary supplement producing anticancer effect at low doses with minimized toxicities would be a promising strategy for cancer treatment.
View Article and Find Full Text PDFA Complete Sojourn of Liposomes in Breast Cancer Therapy: Types, Preparation Techniques, Lipid Selection, and Critical Quality Attributes.
Curr Drug Res Rev
July 2025
Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, 142001, India.
Breast Cancer (BC) continues to exist as the leading cause of cancer-related deaths among women globally. The burden of BC continues to rise despite extensive research efforts dedicated to its diagnosis, prevention, and management. In recent years, nanotherapeutics have shown promising advancements over conventional therapies, including better drug encapsulation, reduced toxicity, multiplied stability, and extended half-life through addressing the limitations of traditional diagnostic and treatment methods.
View Article and Find Full Text PDFFocused ultrasound-mediated temozolomide delivery into intact blood-brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma.
Fluids Barriers CNS
August 2025
Department of Neurosurgery, Stereotactic and Functional Neurosurgery Division, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Background: Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults, characterized by rapid proliferation and invasive infiltration into normal brain tissue. Despite maximal resection and temozolomide (TMZ) chemotherapy, over 80% of GBM cases recur near the resection margin, highlighting the need for improved therapeutic strategies. The blood–brain barrier (BBB) remains a major obstacle to effective drug delivery, limiting TMZ penetration into infiltrative tumor regions.
View Article and Find Full Text PDFPrecise antibody delivery to the brain via nanobubble-actuated focused ultrasound alleviates depression.
Proc Natl Acad Sci U S A
September 2025
Translational Research in Ultrasound Theranostics Laboratory, School of Biomedical Engineering, ShanghaiTech University, Shanghai 201210, China.
Precise, noninvasive drug delivery to small but important brain regions is challenging and highly desired given the brain's inherent complexity and heterogeneous nature. Here, we report an approach utilizing focused ultrasound (FUS) combined with nanobubbles to successfully navigate this challenge. Compared to traditional microbubbles, nanobubbles exhibit superior acoustic properties.
View Article and Find Full Text PDF